Madison Avenue Partners, LP Cyclerion Therapeutics, Inc. Transaction History

Madison Avenue Partners, LP

  • $812 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$2.46 - $5.84 $326,119 - $774,202
-132,569 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.8 - $13.43 $238,624 - $1.78 Million
132,569 New
132,569 $361,000

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0
View Full List

About Cyclerion Therapeutics, Inc.

CYCN Quotes by TradingView
  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $209M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Madison Avenue Partners, LP Portfolio

Follow Madison Avenue Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Avenue Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Madison Avenue Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email